%0
Generic
%T
Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms
%A Grünwald, Viktor
%A Powles, Thomas
%A Eto, Masatoshi
%A Kopyltsov, Evgeny
%A Rha, Sun Young
%A Porta, Camillo
%A Motzer, Robert
%A Hutson, Thomas E.
%A Méndez-Vidal, María José
%A Hong, Sung-Hoo
%A Winquist, Eric
%A Goh, Jeffrey C.
%A Maroto, Pablo
%A Buchler, Tomas
%A Takagi, Toshio
%A Burgents, Joseph E.
%A Perini, Rodolfo
%A He, Cixin
%A Okpara, Chinyere E.
%A McKenzie, Jodi
%A Choueiri, Toni K.
%I Frontiers Media SA
%@ 2234-943X
%K Cancer Research
%K Oncology
%D 2024
%C Frontiers Media SA
%U http://slubdd.de/katalog?TN_libero_mab2